Status:
COMPLETED
The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
Lead Sponsor:
Hôpital Universitaire Sahloul
Conditions:
a Randomized Double-blind Study
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Quercetin is one of the flavonoids. Quercetin as well as rutin are recognized to be among the most active of the flavonoids. It is to quercetin that several medicinal plants, including ginkgo and St. ...
Detailed Description
Type of study: a randomized, double-blind study using the Quercetine in the treatment of patients with SARS COV2 (covid-19) Quercetin is extracted from a variety of plant sources, including the onion ...
Eligibility Criteria
Inclusion
- all patients attending the emergency department for influenza-like illness.
- Being over 18 years old
Exclusion
- Any patient requiring admission
- Non-consenting patients
Key Trial Info
Start Date :
January 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04851821
Start Date
January 4 2021
End Date
June 30 2021
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riadh Boukef
Sahloul, Sousse Governorate, Tunisia